MARKET RADAR
SENSEX     NIFTY      Refresh
Moneycontrol.com India | Notes to Account > Pharmaceuticals > Notes to Account from Emergy Pharma - BSE: 524812, NSE: N.A
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > NOTES TO ACCOUNTS - Emergy Pharma
Emergy Pharma
BSE: 524812|ISIN: INE586C01016|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Emergy Pharma is not traded in the last 30 days
Emergy Pharma is not listed on NSE
« Sep 99
Notes to Accounts Year End : Sep '08
a) i) No Provision has been made towards provident fund contribution
 and other retirement benefits for employees (amount unquantifiable).
    
 ii) The Company has not calculated the effect on account of deferred
 taxation and the same is not ascertainable due to lack of certainty of
 future business.
    
 iii) The Company has not ascertained the effect of Impairment of Assets
 as per Accounting Standard (AS) 28 ''Impairment of assets.
    
 b) i) During the year the Company has settled the amount payable to
 IDBI Bank under One Time Settlement (OTS) Scheme.
    
 ii) No Provision has been made towards interest on Income Tax Payable
 (amount undetermined as no confirmation letters received from the
 concerned parties).
    
 ii) No Provision has been made towards over due charges on hire
 purchase loan from Model Finance Corporation Limited (amount
 undetermined as no confirmation letter received from the party) and the
 case Is pending before the Metropolitan Magistrate, Nampally,
 Hyderabad.
    
 c) Contingent Liabilities not provided in respect of:
    
 Claims against the company not acknowledged as debts: Custom Duty was
 Rs. 41, 73 , 499 / - which is pending before the Commissioner of
 Customs, Excise and Service Tax (Appeals), Visakhapatnam,
    
 d) Expenditure on employees in respect of remuneration of not less than
 Rs.24,00,000/- per annum, if employed throughout the year or
 Rs.2,00,000/- per month, if employed for part of the year is NIL.
    
 e) Managerial Remuneration : NIL
    
 f) The company has not received any information from any of the
 suppliers of their being Small Scale Industrial Unit. Hence, the
 amounts due to Small Scale Industrial Units outstanding as on 30th
 September, 2008 are not ascertainable.
    
 g) The balances of Sundry Creditors, advances and current accounts are
 subject to confirmation from the respective parties.
    
 h) Previous year figures have been regrouped wherever necessary.
    
 i) Paisa have been rounded off to the nearest rupee,
    
 j) Earnings / (Loss) per Share:
    
 Basic & Diluted:
    
 The Company reports basic and diluted Earnings / (Loss) per Share in
 accordance with AS-20 ''Earnings per Share''. The Basic & Diluted
 Earnings / (Loss) per Share has been calculated by dividing the
 Earnings / (Loss) by the weighted average number of equity shares and
 weighted average potentially dilutive equity shares outstanding during
 the accounting period.
    
 b) Net Earnings / (Loss) after tax available for equity shareholders
 Rs. 2,09,68,185 /-
    
 c) Basic/diluted Earning / (Loss) (in Rupees) per share of Rs.10 each
 4.41
    
 k) The Company''s main business is Manufacture of Fine Chemicals and all
 the other activities of the Company revolve around the main business
 and as such there is no separate reportable segments as per the
 Accounting Standard (AS-17) Segment reporting.
Source : Dion Global Solutions Limited
Quick Links for emergypharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.